Chitosan-Based Delivery of Avian Reovirus Fusogenic Protein p10 Gene: In Vitro and In Vivo Studies towards a New Vaccine against Melanoma

Chitosan-Based Nanoparticles for Intracellular Delivery of ISAV Fusion Protein cDNA into Melanoma Cells: A Path to Develop Oncolytic Anticancer Therapies

(2020) Claudia Robles-Planells et al.   MEDIATORS OF INFLAMMATION

Lithraea caustic (Litre) Extract Promotes an Antitumor Response Against B16 Melanoma

(2019) Claudia Robles-Planells et al.   Frontiers in Pharmacology

The natural product chitosan enhances the anti-tumor activity of natural killer cells by activating dendritic cells

(2018) Xinxin Li et al.   OncoImmunology

Fusogenic Viruses in Oncolytic Immunotherapy

(2018) Teresa Krabbe et al.   Cancers

Trial Watch: Oncolytic viro-immunotherapy of hematologic and solid tumors

(2018) Jonathan G. Pol et al.   OncoImmunology

Engineered oncolytic viruses to treat melanoma: where are we now and what comes next?

(2018) Luke D. Rothermel et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Dead Tumor Cells Expressing Infectious Salmon Anemia Virus Fusogenic Protein Favor Antigen Cross-Priming In Vitro

(2017) Jonathan Morales et al.   Frontiers in Immunology

Reovirus FAST Protein Enhances Vesicular Stomatitis Virus Oncolytic Virotherapy in Primary and Metastatic Tumor Models

(2017) Fabrice Le Boeuf et al.   Molecular Therapy-Oncolytics

Antitumour responses induced by a cell-based Reovirus vaccine in murine lung and melanoma models

(2016) Ciorsdan A. Campion et al.   BMC CANCER

The Vaccine Adjuvant Chitosan Promotes Cellular Immunity via DNA Sensor cGAS-STING-Dependent Induction of Type I Interferons

(2016) Elizabeth. C. Carroll et al.   IMMUNITY

Combination Therapy With Reovirus and Anti-PD-1 Blockade Controls Tumor Growth Through Innate and Adaptive Immune Responses

(2016) Karishma Rajani et al.   MOLECULAR THERAPY

Oncolysis by paramyxoviruses: multiple mechanisms contribute to therapeutic efficiency

(2015) Olga V Matveeva et al.   Molecular Therapy-Oncolytics

Anti-tumor Effects of Gene Therapy with GALV Membrane Fusion Glycoprotein in Lung Adenocarcinoma

(2014) Bing Zhu et al.   CELL BIOCHEMISTRY AND BIOPHYSICS

Spectrum and Mechanisms of Inflammasome Activation by Chitosan

(2014) C. L. Bueter et al.   JOURNAL OF IMMUNOLOGY

Reovirus FAST proteins: virus-encoded cellular fusogens

(2014) Marta Ciechonska et al.   TRENDS IN MICROBIOLOGY

Chitosan but Not Chitin Activates the Inflammasome by a Mechanism Dependent upon Phagocytosis

(2011) Chelsea L. Bueter et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Fusogenic membrane glycoproteins induce syncytia formation and death in vitro and in vivo: a potential therapy agent for lung cancer

(2009) E-H Lin et al.   CANCER GENE THERAPY

Synergistic Effects of Oncolytic Reovirus and Cisplatin Chemotherapy in Murine Malignant Melanoma

(2009) H. S. Pandha et al.   CLINICAL CANCER RESEARCH

Immune-Mediated Antitumor Activity of Reovirus Is Required for Therapy and Is Independent of Direct Viral Oncolysis and Replication

(2009) R. J. Prestwich et al.   CLINICAL CANCER RESEARCH

Reciprocal Human Dendritic Cell-Natural Killer Cell Interactions Induce Antitumor Activity Following Tumor Cell Infection by Oncolytic Reovirus

(2009) R. J. Prestwich et al.   JOURNAL OF IMMUNOLOGY

Tumor Infection by Oncolytic Reovirus Primes Adaptive Antitumor Immunity

(2008) R. J. Prestwich et al.   CLINICAL CANCER RESEARCH

Inflammatory tumour cell killing by oncolytic reovirus for the treatment of melanoma

(2008) F Errington et al.   GENE THERAPY